|
ZNF530 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.941800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.634000E-01 |
| Normal-vs-Stage2 |
3.168000E-01 |
| Normal-vs-Stage3 |
2.530400E-01 |
| Normal-vs-Stage4 |
4.233800E-04 |
| Stage1-vs-Stage2 |
4.015000E-01 |
| Stage1-vs-Stage3 |
1.116420E-01 |
| Stage1-vs-Stage4 |
5.582200E-04 |
| Stage2-vs-Stage3 |
9.803800E-02 |
| Stage2-vs-Stage4 |
2.158000E-03 |
| Stage3-vs-Stage4 |
6.629700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.087000E-01 |
| Normal-vs-AfricanAmerican |
2.800800E-01 |
| Normal-vs-Asian |
6.792000E-01 |
| Caucasian-vs-AfricanAmerican |
5.795200E-01 |
| Caucasian-vs-Asian |
7.700600E-01 |
| AfricanAmerican-vs-Asian |
9.307000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.876200E-01 |
| Normal-vs-Female |
8.416500E-02 |
| Male-vs-Female |
1.247160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.883400E-01 |
| Normal-vs-Extreme_Weight |
5.700600E-01 |
| Normal-vs-Obese |
2.432800E-01 |
| Normal-vs-Extreme_Obese |
2.672000E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.916150E-01 |
| Normal_Weight-vs-Obese |
8.392000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.510250E-01 |
| Extreme_Weight-vs-Obese |
1.016580E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.213800E-01 |
| Obese-vs-Extreme_Obese |
1.361800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.772600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.078000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.912800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.311400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.846600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.336400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.596800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.902800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.497800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.573600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.845910E-02 |
| Normal-VS-Type2 PRCC |
2.079200E-03 |
| Normal-VS-KIRP CIMP |
8.591600E-01 |
| Normal-VS-Unclassified PRCC |
4.863000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.29470000276299E-08 |
| Type1 PRCC-VS-KIRP CIMP |
2.299000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.421800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.210400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.797200E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.910600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.940400E-01 |
| Normal-vs-N1 |
9.800000E-01 |
| Normal-vs-N2 |
2.938700E-03 |
| N0-vs-N1 |
5.331400E-01 |
| N0-vs-N2 |
8.852300E-02 |
| N1-vs-N2 |
2.541900E-03 |
|
|
